NVAX Financial Facts
Net loss: -66.25MInterest income: 554K
See Full Income Statement
Deferred rent: 12.24M
Total liabilities and stockholders' equity: 459.63M
See Full Balance Sheet
Novavax, Inc. (NVAX) Earnings
|
Expand Research on NVAX
Next EPS Date | 5/7/24 | EPS Growth Rate | +72.7% |
---|---|---|---|
Average EPS % Beat Rate | -43.3% | Revenue Growth Rate | +85.7% |
Average % Move 1-Wk after EPS | -8.2% | Normal Earnings Time | After Close |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
8/8/22 | Q222 | -$6.53 | $5.50 | -$12.03 | $186B | $1.02B | Details | ||||
2/28/22 | Q421 | -$11.28 | -$0.55 | -$10.73 | $222M | $442.77M | Details | ||||
11/8/22 | Q322 | -$4.31 | $1.63 | -$5.94 | $178.84M | $623.9M | Details | ||||
11/9/20 | Q320 | -$3.21 | N/A | N/A | $157M | $230.56M | N/A | Details | |||
11/8/22 | Q322 | -$2.15 | $1.63 | -$3.78 | $735M | $623.9M | Details | ||||
3/1/21 | Q420 | -$2.70 | -$1.15 | -$1.55 | $279.66M | $347.92M | N/A | Details | |||
8/5/21 | Q221 | -$4.75 | -$3.63 | -$1.12 | $298M | $387.87M | N/A | Details | |||
2/28/23 | Q422 | -$2.28 | -$1.19 | -$1.09 | $357M | $383.14M | = | Details |